The Buzz on Taysha Gene Therapies and More: A Market Overview

Shares of Taysha Gene Therapies, Inc. TSHA soared in pre-market trading today following a notable uptick in FY23 EPS results.

For fiscal year 2023, the company reported losses of 96 cents per share, a significant improvement from the $3.78 per share loss recorded in the previous year. As of Dec. 31, 2023, Taysha boasted $143.9 million in cash and cash equivalents.

In addition to its financials, the company released updates on its clinical endeavors, including successful dosing in cohort one of the REVEAL Phase 1/2 adolescent and adult trial and expansion plans within North America.

This positive news catapulted Taysha Gene Therapies shares up by an impressive 27.1% to $2.86 in pre-market trading.

Here’s a glance at other stocks making moves in pre-market trading.

Winners

• The early bird firm, ETAO International Co., Ltd. ETAO, saw a whopping gain of 200.4% to $0.4296 in pre-market action after announcing a reverse stock split.
• Oblong, Inc. OBLG surged by 48.2% to $0.20 pre-market, celebrating strong financials and a business update from the previous quarter.
• Flying high, BYND Cannasoft Enterprises Inc. BCAN climbed 44% to $0.0288 in early trading after taking a slight tumble just a day before. Aegis Capital led a successful $7.0 million underwritten public offering for the company.
• Mangoceuticals, Inc. MGRX saw a sweet rise of 40.5% to $0.2698 pre-market after a modest 4% gain on the prior trading day.
• EZFill Holdings Inc. EZFL bounced back, gaining 18% to hit $1.90 pre-market after experiencing a setback of 9% on Tuesday.
• SCWorx Corp. WORX continued its upward trajectory, rising 16.9% to $3.32 in pre-market trading following a significant surge of around 54% the day before.
• BitFuFu Inc. FUFU gained 11.7% to $6.03 in pre-market trading after a notable 32% increase on the prior trading day.
• Canopy Growth Corporation CGC witnessed a growth spurt of 14.4% to $4.38 pre-market after Vice President Kamala Harris called for the DEA to reconsider its stance on marijuana.
• Getty Images Holdings, Inc. GETY surged 14% to $5.36 pre-market following an impressive fourth-quarter revenue report and strong FY24 revenue guidance from Getty Images.

Losers

• Ontrak, Inc. OTRK took a tumble, dropping 20.5% to $0.35 pre-market after a remarkable 131% surge the day before.
• Momentus Inc. MNTS fell 19.1% to $0.4803 pre-market, reversing course following a 17% jump on Tuesday propelled by a recent US patent grant.
• Aquestive Therapeutics, Inc. AQST dropped 14.8% to $4.55 pre-market after pricing a $75 million underwritten public offering of 16,666,667 common shares at $4.50 per share.
• Verb Technology Company, Inc. VERB slid 14.2% to $0.3309 pre-market after a 7% rise on Tuesday. The company recently introduced Facebook and Instagram social shopping integration through Market.live and expanded its retail brand reach on its livestream social shopping platform.
• Harrow, Inc. HROW plummeted 14.6% to $9.09 pre-market following lower-than-expected fourth-quarter results.
• NuScale Power Corporation SMR shares took a dive of 6.8% to $6.13 pre-market after Wells Fargo downgraded the stock and revised its price target downward based on recent performance.
• CERo Therapeutics Holdings, Inc. CERO declined 6.4% to $2.25 in pre-market trading following a 14% surge on the prior trading day.
• Clearmind Medicine Inc. CMND saw a 6.2% drop to $1.21 pre-market after announcing a divisional patent approval from the China National Intellectual Property Administration.
• MaxCyte, Inc. MXCT shares tumbled 5.8% to $4.20 after a 7% increase on Tuesday. The company had reported strong fourth-quarter financials the previous week and shared bullish FY24 guidance.
• Society Pass Incorporated SOPA shares fell 5% to $0.1456 in pre-market trading.

 

Now Read This: Micron, Signet Jewelers And 3 Stocks To Watch Heading Into Wednesday